49
Participants
Start Date
November 12, 2020
Primary Completion Date
September 15, 2024
Study Completion Date
June 30, 2025
Saracatinab
125 mg once daily by mouth for 24 weeks
Placebo
once daily by mouth for 24 weeks
Icahn School of Medicine at Mount Sinai, New York
Baylor University Medical Center (BUMC), Dallas
National Jewish Health, Denver
Yale University School of Medicine, New Haven
Collaborators (1)
Yale University
OTHER
Icahn School of Medicine at Mount Sinai
OTHER
AstraZeneca
INDUSTRY
National Center for Advancing Translational Sciences (NCATS)
NIH
Baylor University
OTHER
International Center for Health Outcomes and Innovation Research
OTHER
National Jewish Health
OTHER